Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace L Guo

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|May 28, 2022
Gut-specific inhibition of PPARα as a novel approach of NAFLD treatmentLanjing Zhang, Grace L Guo
Current Environmental Health Reports|May 16, 2019
Understanding Environmental Contaminants' Direct Effects on Non-alcoholic Fatty Liver Disease ProgressionLaura E Armstrong, Grace L Guo
Current Pharmacology Reports|October 7, 2017
Role of FXR in Liver Inflammation during Nonalcoholic SteatohepatitisLaura E Armstrong, Grace L Guo
Biomed Research International|October 5, 2016
Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth FactorsJustin D Schumacher, Grace L Guo
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2011
Steatosis DeLIVERs high-sensitivity C-reactive proteinJames P Luyendyk, Grace L Guo
Handbook of Experimental Pharmacology|June 16, 2019
Pharmacologic Modulation of Bile Acid-FXR-FGF15/FGF19 Pathway for the Treatment of Nonalcoholic SteatohepatitisJustin D Schumacher, Grace L Guo
Toxicology and Applied Pharmacology|September 8, 2015
Mechanistic review of drug-induced steatohepatitisJustin D Schumacher, Grace L Guo
Hepatology Communications|April 14, 2023
FXR and NASH: an avenue for tissue-specific regulationZakiyah Henry, Vik Meadows, Grace L Guo
Molecular Pharmacology|January 18, 2024
Circadian Regulation of Endocrine Fibroblast Growth Factors on Systemic Energy MetabolismZhenning Yang, Helmut Zarbl, Grace L Guo
Molecular Pharmacology|March 1, 2025
Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver diseaseVeronia Basaly, Anisha Bhattacharya, Grace L Guo
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|May 28, 2022
Gut-specific inhibition of PPARα as a novel approach of NAFLD treatmentLanjing Zhang, Grace L Guo
Current Environmental Health Reports|May 16, 2019
Understanding Environmental Contaminants' Direct Effects on Non-alcoholic Fatty Liver Disease ProgressionLaura E Armstrong, Grace L Guo
Current Pharmacology Reports|October 7, 2017
Role of FXR in Liver Inflammation during Nonalcoholic SteatohepatitisLaura E Armstrong, Grace L Guo
Biomed Research International|October 5, 2016
Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth FactorsJustin D Schumacher, Grace L Guo
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2011
Steatosis DeLIVERs high-sensitivity C-reactive proteinJames P Luyendyk, Grace L Guo
Handbook of Experimental Pharmacology|June 16, 2019
Pharmacologic Modulation of Bile Acid-FXR-FGF15/FGF19 Pathway for the Treatment of Nonalcoholic SteatohepatitisJustin D Schumacher, Grace L Guo
Toxicology and Applied Pharmacology|September 8, 2015
Mechanistic review of drug-induced steatohepatitisJustin D Schumacher, Grace L Guo
Hepatology Communications|April 14, 2023
FXR and NASH: an avenue for tissue-specific regulationZakiyah Henry, Vik Meadows, Grace L Guo
Molecular Pharmacology|January 18, 2024
Circadian Regulation of Endocrine Fibroblast Growth Factors on Systemic Energy MetabolismZhenning Yang, Helmut Zarbl, Grace L Guo
Molecular Pharmacology|March 1, 2025
Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver diseaseVeronia Basaly, Anisha Bhattacharya, Grace L Guo
Pageof 15